INTRODUCTION
Transferrin receptor (TfR), a membranous protein that regulates iron uptake into cells, is expressed strongly in erythroblasts, which are constantly reproducing in the bone marrow to internalize iron for the synthesis of haemoglobin, and also moderately in various cells in the proliferation phase [1 -4] . On the other hand, the expression of TfR is regulated by iron regulating protein (IRP) in the cytoplasm [5] . In the iron de ciency state, IRP moves to combine with the iron reactive element (IRE) at the untranslated region on the 3 0 -end of TfR mRNA and protects mRNA against degradation by RNase, resulting in up-regulation of TfR [6] . Alternatively, the presence of excess iron leads to the dissociation of IRP from IRE, and RNase degrades TfR mRNA, resulting in a reduction of the translation of mRNA [7] . TfR on the cell membrane associates with iron-saturated transferrin (Tf) and this complex is internalized into cells. After delivering iron into the cytoplasm, TfR dissociates from Tf and binds again to the cell membrane for its recycling [8] . In the production and recycling process, some of the TfR leaks to the cell outside as soluble transferrin receptor (sTfR) [9] . It has been reported that the sTfR concentration re ects the total mass of TfR in a body [10] .
Measurement of serum sTfR has been reported to indicate two different clinical symptoms. The major one is an indication of iron de ciency. Kohgo et al. have reported that they could even diagnose subclinical iron de ciency at the pre-anemic stage [11] . The second is the possibility to detect erythropoietic function, because erythroblasts strongly express TfR [10, 12] .
